Table 2.
Clinical characteristics of ulcerative colitis patients.
| Variable | Patients (n = 30) |
|---|---|
| Duration of IBD (years) | |
| mean ± SD | 6.2 ± 5.7 |
| min–max | 2–30 |
| Age at diagnosis, n (%) | |
| <40 anos | 14 (46.7%) |
| ≥40 anos | 16 (53.3%) |
| Location, n (%) | |
| Proctitis | 5 (16.7%) |
| Left-sided colitis | 7 (23.3%) |
| Pancolitis | 18 (60.0%) |
| Current medical therapy for IBD, n (%) | |
| Aminosalicylates | 28 (93.3%) |
| Azathioprine | 13 (43.3%) |
| Biological therapy | 8 (26.7%) |